Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran , shahbazi@med.mui.ac.ir
Abstract: (725 Views)
Background:This research was conducted to compare dosiomics features extracted from planning target volume (PTV) between the two three-dimensional conformal radiation therapy (3D-CRT) and helical tomotherapy (HT) techniques in nasopharyngeal cancer. Materials and Methods: 3D-CRT plans were designed for ten nasopharyngeal patients previously treated with HT. For both treatment techniques, the total prescription dose was 70 Gray in 33 fractions. At first, the dosimetric parameters, including mean dose, conformity index (CI), and homogeneity index (HI), were calculated for two techniques. Then, using 3D-Slicer software, dosiomics features were extracted from the dose matrix of PTV. Results: In comparing the plans regarding dosimetric parameters, HT plans had a lower mean dose and higher CI (p-value <0.01 and <0.001, respectively). HI had no statistically difference between the two groups (p>0.9). Among 93 features extracted from PTV70, only 40 features including eight features from the first-order group, ten features from the gray-level co-occurrence matrix group (GLCM), seven features from the gray-level dependence matrix group (GLDM), ten features from the gray-level run-length matrix group (GLRLM), four features from the gray-level size-zone matrix group (GLSZM), and one feature from the neighboring gray-tone difference matrix group (NGTDM) were found to be significantly different between the two groups. Conclusion: According to the results, the dosiomics features can distinguish the differences between dose distributions in different studied plans. However, more studies should be done in selecting the most suitable features for use in evaluating the quality of the treatment plans.
1. 1. Murakami Y, Soyano T, Kozuka T, et al. (2022) Dose-based radiomic analysis (Dosiomics) for intensity modulated radiation therapy in patients with prostate cancer: Correlation between planned dose distribution and biochemical failure. Int J Radiat Oncol Biol Phys, 112(1): 247-259. [DOI:10.1016/j.ijrobp.2021.07.1714]
2. Liang B, Yan H, Tian Y, et al. (2019) Dosiomics: Extracting 3D spatial features from dose distribution to predict incidence of radiation pneumonitis. Front Oncol, 9: 1-7. [DOI:10.3389/fonc.2019.00269]
3. Adachi T, Nakamura M, Shintani T, et al. (2021) Multi-institutional dose-segmented dosiomic analysis for predicting radiation pneumonitis after lung stereotactic body radiation therapy. Med Phys, 48(4): 1781-1791. [DOI:10.1002/mp.14769]
4. Ren W, Liang B, Sun C, et al. (2021) Dosiomics-based prediction of radiation-induced hypothyroidism in nasopharyngeal carcinoma patients. Phys Medica, 89: 219-225. [DOI:10.1016/j.ejmp.2021.08.009]
5. Pota M, Scalco E, Sanguineti G, et al. (2017) Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification. Artif Intell Med, 81: 41-53. [DOI:10.1016/j.artmed.2017.03.004]
6. Trott KR, Doerr W, Facoetti A, et al. (2012) Biological mechanisms of normal tissue damage: Importance for the design of NTCP models. Radiother Oncol, 105(1): 79-85. [DOI:10.1016/j.radonc.2012.05.008]
7. Giraud P, Giraud P, Gasnier A, et al. (2019) Radiomics and machine learning for radiotherapy in head and neck cancers. Front Oncol, 9: 1-13. [DOI:10.3389/fonc.2019.00174]
8. Puttanawarut C, Sirirutbunkajorn N, Khachonkham S, et al. (2021) Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients. Radiat Oncol, 16: 1-9. [DOI:10.1186/s13014-021-01950-y]
9. Gabryś HS, Buettner F, Sterzing F, et al. (2018) Design and selection of machine learning methods using radiomics and dosiomics for normal tissue complication probability modeling of xerostomia. Front Oncol, 8: 1-20. [DOI:10.3389/fonc.2018.00035]
10. van Dijk LV, Brouwer CL, van der Schaaf A, et al. (2017) CT image biomarkers to improve patient-specific prediction of radiation-induced xerostomia and sticky saliva. Radiother Oncol, 122: 185-191. [DOI:10.1016/j.radonc.2016.07.007]
11. Sheikh K, Lee SH, Cheng Z, et al. (2019) Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands. Radiat Oncol, 14: 1-11. [DOI:10.1186/s13014-019-1339-4]
12. Bruixola G, Remacha E, Jiménez-Pastor A, et al. (2021) Radiomics and radiogenomics in head and neck squamous cell carcinoma: Potential contribution to patient management and challenges. Cancer Treat Rev, 99. [DOI:10.1016/j.ctrv.2021.102263]
13. Hirose T aki, Arimura H, Ninomiya K, et al. (2020) Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy. Sci Rep, 10: 1-9. [DOI:10.1038/s41598-020-77552-7]
14. Krafft SP, Rao A, Stingo F, et al. (2018) The utility of quantitative CT radiomics features for improved prediction of radiation pneumonitis. Med Phys, 45(11): 5317-5324. [DOI:10.1002/mp.13150]
15. Wu A, Li Y, Qi M, et al. (2020) Dosiomics improves prediction of locoregional recurrence for intensity modulated radiotherapy treated head and neck cancer cases. Oral Oncol, 104(2): 104625. [DOI:10.1016/j.oraloncology.2020.104625]
16. Tai DT, Oanh LT, Phuong PH, et al. (2022) Dosimetric and radiobiological comparison in head-and-neck radiotherapy using JO-IMRT and 3D-CRT. Saudi J Biol Sci, 29(8): 103336. [DOI:10.1016/j.sjbs.2022.103336]
17. Ibrahim MS, Attalla EM, El Naggar M, et al. (2019) Dosimetric comparison between three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT) in the treatment of different stages of nasopharyngeal carcinoma. J Radiother Pract, 18(1): 16-20. [DOI:10.1017/S1460396918000377]
18. Bišof V, Rakušić Z, Bibić J, et al. (2018) Comparison of intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and a 3-dimensional conformal parotid gland-sparing radiotherapy (ConPas 3D-CRT) in treatment of nasopharyngeal carcinoma: a mono-institutional experience. Radiol Medica, 123(3): 217-226. [DOI:10.1007/s11547-017-0824-9]
19. Gabryś HS, Buettner F, Sterzing F, et al. (2017) Parotid gland mean dose as a xerostomia predictor in low-dose domains. Acta Oncol (Madr), 56(9): 1197-1203. [DOI:10.1080/0284186X.2017.1324209]
20. Lu S, Fan H, Hu X, et al. (2021) Dosimetric comparison of helical tomotherapy, volume-modulated arc therapy, and fixed-field intensity-modulated radiation therapy in locally advanced nasopharyngeal carcinoma. Front Oncol, 11: 1-10. [DOI:10.3389/fonc.2021.764946]
21. Chen W, Yang X, Jiang N, et al. (2017) Intensity-modulated radiotherapy, volume-modulated arc therapy and helical tomotherapy for locally advanced nasopharyngeal carcinoma: A dosimetric comparison. Transl Cancer Res, 6(5): 929-939. [DOI:10.21037/tcr.2017.09.48]
22. Zhou L, Chen J, Shen W, et al. (2020) Thyroid V50 is a risk factor for hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: A retrospective study. Radiat Oncol, 15(1): 1-8. [DOI:10.1186/s13014-020-01490-x]
23. Fedorov A, Beichel R, Kalpathy-Cramer J, et al. (2012) 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging, 30(9): 1323-1341. [DOI:10.1016/j.mri.2012.05.001]
24. Sun L, Smith W, Kirkby C (2023) Stability of dosiomic features against variations in dose calculation: An analysis based on a cohort of prostate external beam radiotherapy patients. J Appl Clin Med Phys, 24(5): 1-14. [DOI:10.1002/acm2.13904]
25. Placidi L, Lenkowicz J, Cusumano D, et al. (2020) Stability of dosomics features extraction on grid resolution and algorithm for radiotherapy dose calculation. Phys Medica, 77(3): 30-35. [DOI:10.1016/j.ejmp.2020.07.022]
26. Placidi L, Gioscio E, Garibaldi C, et al. (2021) A multicentre evaluation of dosiomics features reproducibility, stability and sensitivity. Cancers (Basel), 13(15). [DOI:10.3390/cancers13153835]
Mirzaeiyan M, Najafizadeh N, Saeb M, Shahbazi-Gahrouei D. Dosiomics-based comparison of dose distributions in nasopharyngeal cancer patients: 3D-CRT versus Tomotherapy. Int J Radiat Res 2024; 22 (2) :419-425 URL: http://ijrr.com/article-1-5452-en.html